Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens.
about
Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.Vaccines against drugs of abuse: where are we now?The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuseEffect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.Adjuvants for vaccines to drugs of abuse and addiction.Dynamic vaccine blocks relapse to compulsive intake of heroin.Conjugate Vaccine Immunotherapy for Substance Use Disorder.Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.Biologics to treat substance use disorders: Current status and new directionsMethamphetamine Vaccines: Improvement through Hapten Design.Current status and future prospects for the development of substance abuse vaccines.Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse.Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose.
P2860
Q33751968-37907EB0-0AB9-4A9D-9C29-56A976EAC611Q33776777-08D97C93-AADB-4A2D-A5B0-17C2D0A95CF4Q34476304-3D2DE070-34C9-4D52-82E6-EE4D7A19EB5DQ35163178-F7A6FF84-2218-461F-9C48-9DC1B151D2B3Q35207004-1440C320-7FF3-4584-9C5F-DFCAFEAB2C50Q35493923-55572512-5E8C-4291-9C4B-B91593C1A4A1Q36895574-2F80E6D7-9CDB-4EB8-A1BF-2950113F0D86Q39387013-C2DF914D-8BC0-40FA-9806-0CEE28690781Q39519649-29E4F6B6-41CD-4655-9C92-71CB7968AD72Q39576940-69081DD3-22C5-459B-9C81-A7853A3DD06AQ42113438-55880EE9-0A2C-4B3F-A7AF-E847800F9C23Q43076031-FE6FA4D9-0E39-44C2-86FE-66CFADAB92E1Q45257107-48BD7E77-3FFA-4BDE-9A95-4F737EED1C87Q47253367-B25F45EF-5400-4E6B-BDB0-4D695F23A3D8Q47384878-7CA76F46-0D9B-4893-81AC-F2A07FDFD732Q52317280-BAEC096C-C152-4B4F-8199-4C3B43BCBB34
P2860
Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@en
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@nl
type
label
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@en
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@nl
prefLabel
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@en
Reduced antinociception of opi ...... odone and hydrocodone haptens.
@nl
P2093
P2860
P356
P1476
Reduced antinociception of opi ...... codone and hydrocodone haptens
@en
P2093
Ashli M Tucker
Morgan Le Naour
Paul R Pentel
Philip S Portoghese
Tara M Hawley
Theresa M Harmon
P2860
P304
P356
10.1021/JM3013745
P407
P577
2013-01-15T00:00:00Z